A U.S. Food and Drug Administration advisory panel will consider whether to approve a drug that its manufacturer says increases women’s sexual desire.
The drug, called flibanserin, was developed by German pharmaceutical company Boehringer Ingelheim. Michael Sand, director of clinical research on flibanserin said the company believes “women deserve options and we’re hoping flibanserin may represent a safe and effective option for many women,” The Washington Post reported Monday.
Full story: U.S. panel to consider ‘Viagra for women’